Healthcare Informatics October 10, 2018
Mark Hagland

The DoJ’s approval of the CVS-Aetna merger signals a new phase in the healthcare business world—and it’s time for patient care executives to rethink the meaning of competition

As Associate Editor Heather Landi noted in her news report Oct. 10, on Wednesday, the Department of Justice (DoJ) approved a proposed $69 billion merger between CVS Health and health insurer Aetna, after Aetna entered into an agreement with the Department to divest its Medicare Part D prescription drug plan business.

“The deal,” Landi wrote, “is the latest in a wave of combinations among healthcare companies, including many pharmacy benefit manager (PBM) and insurer integrations. Last month, the Justice Department approved Cigna’s $67 billion takeover of Express Scripts. CVS Health announced in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Health System / Hospital, Healthcare System, Insurance, Mergers & Acquisitions / JV, Payer, Pharma, Physician, Primary care, Provider, Retail care, Trends
Transforming The Narrative On Homelessness
How Hospitals Can Avoid a Price Transparency Audit: Part III
Models adjusting for geography show racial gaps in telehealth use
CDC: Thanks in part to fewer COVID-19 deaths, life expectancy rises slightly from 2021 to 2022
Federal Legislation And State Policy Efforts Promote Access To And Use of Discounted Cash Prices

Share This Article